Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: Results of the randomized phase II LITESPARK-013 study

被引：5

作者：

Agarwal, N. ^{[1
]}

Brugarolas, J. ^{[2
]}

Ghatalia, P. ^{[3
]}

George, S. ^{[4
]}

Haanen, J. B. A. G. ^{[5
]}

Gurney, H. P. ^{[6
]}

Ravilla, R. ^{[7
]}

Van der Veldt, A. A. M. ^{[8
]}

Beuselinck, B. ^{[9
]}

Pokataev, I. ^{[10
]}

Suelmann, B. B. ^{[11
]}

Tuthill, M. ^{[12
]}

Vaena, D. ^{[13
]}

Zagouri, F. ^{[14
]}

Wu, J. ^{[15
]}

Liu, Y. ^{[15
]}

Perini, R. ^{[15
]}

Merchan, J. R. ^{[16
]}

Atkins, M. B. ^{[17
]}

机构：

[1] Huntsman Canc Inst, Oncol Internal Med Dept, Salt Lake City, UT USA

[2] Univ Texas Southwestern Med Ctr, Internal Med Hematol Oncol, Dallas, TX USA

[3] Fox Chase Canc Ctr, Hematol Oncol, Philadelphia, PA USA

[4] Roswell Pk Canc Inst, Oncol, Buffalo, NY USA

[5] Netherlands Canc Inst, Oncol, Amsterdam, Netherlands

[6] Macquarie Univ, Oncol, Sydney, NSW, Australia

[7] Albany Canc Ctr, Oncol, New York Oncol Hematol, Albany, NY USA

[8] Erasmus MC, Oncol, Rotterdam, Netherlands

[9] UZ Leuven, Oncol, Leuven, Belgium

[10] City Clin Oncol Hosp 1, Oncol, Moscow, Russia

[11] Univ Med Ctr Utrecht, Med Oncol, Utrecht, Netherlands

[12] Oxford Univ Hosp NHS Fdn Trust, Oncol & Hematol, London, England

[13] West Canc Ctr & Res Inst, Oncol, Germantown, TN USA

[14] Alexandra Reg Gen Hosp, Oncol, Athens, Greece

[15] Merck & Co Inc, Oncol, Rahway, NJ USA

[16] Univ Miami Hosp & Clin, Oncol, Sylvester Canc Ctr, Canc Res Serv, Miami, FL USA

[17] Georgetown Univ, Oncol, Med Ctr, Washington, DC USA

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1111

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1881O

引用

页码：S1011 / S1011

页数：1